It has been shown that TGF-β inhibited TNF-α-induced CXCL1 release in human ECs [35] and TGF-β regulated suppression of inflammatory genes such as CXCL1 and CXCL5 in mammary carcinoma cells [36]. This evidence concerns the gene CXCL1 and breast carcinoma.